Targeted Oncology
@targetedonc
Oncology news and insights from leading researchers and cancer centers.
ID: 726304448
http://targetedonc.com 30-07-2012 15:43:54
42,42K Tweet
20,20K Takipçi
3,3K Takip Edilen
Findings presented at #SOHO2024 showed that there was an 11% decrease from 2018 to 2022 in patients receiving tisagenlecleucel in the third or later relapse. #LEUSM | Society of Hematologic Oncology (SOHO) BCMHouston targetedonc.com/view/tisa-cel-…